Skip to Main Content

Rise and shine, another busy day is on the way. We can tell because our official mascot is bounding about the castle at high speed, eager for a stroll about the neighborhood. Happily, Mrs. Pharmalot is pitching in. As for us, we are recovering after a brief trip where we met interesting people and are now recovering with a needed cup or three of stimulation. Our choice this morning is pumpkin spice with a spot of almond milk. Yum. Meanwhile, here is the usual menu of tidbits. We hope you have a smashing day and, as always, do keep in touch. …

The U.S. National Institutes of Health scientists played “a major role” in developing the Moderna (MRNA) Covid-19 vaccine and NIH Director Francis Collins says the agency intends to defend its claim as co-owner of patents on the shot, Reuters writes. Moderna excluded three NIH scientists as co-inventors of a central patent for its vaccine in its application filed in July. Moderna expects 2021 sales of $15 billion to $18 billion from the COVID-19 vaccine — its first and only commercial product — and up to $22 billion next year. Moderna acknowledged that NIH scientists played a “substantial role” in developing the vaccine, but disagrees with NIH patent claims.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment